Minors using Ritalin: obstacles in Primary Health Care surveillance

Keywords: Primary Health Care; Attention Deficit Disorder with Hyperactivity; Methylphenidate; Family Health Strategy.

Abstract

Objective: to understand how nursing workers from Family Health Strategy teams track children and adolescents using Ritalin. Methods: qualitative study, based on the theoretical references of the essential primary health care attributes. The participants were 27 nurses from the Family Health Strategy. Data collection took place through interviews later submitted to content analysis in the NVivo software. Results: three categories emerged: (Lack of) knowledge about the population who uses Ritalin: co-responsibilities in the process of assistance and difficulties to follow up on the use of Ritalin; Primary care knowledge and know-how in the setting of Ritalin use; The prescription of Ritalin as a demand from schools. Conclusion: the monitoring of children and adolescents who use Ritalin has shortcomings, and primary health care must organize itself to increase and strengthen the care to this population.


References

Ministério da Saúde (BR). Portaria nº 2.436, de 21 de setembro de 2017. Aprova a Política Nacio- nal de Atenção Básica, estabelecendo a revisão de diretrizes para a organização da Atenção Básica, no âmbito do Sistema Único de Saúde (SUS) [Internet]. 2017 [cited Sep 30, 2021]. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt2436_22_09_2017.html

Melo EA, Gomes GG, Carvalho JO, Pereira PHB, Guabiraba KPL. Access regulation to specialized outpatient care and the Primary Health Care in National Policies of SUS. Physis. 2021; 31(1):e310109. doi: https://doi.org/10.1590/S0103-73312021310109

Lima JG, Giovanella L, Fausto MCR, Bosquat A, Silva EV. Essential attributes of Primary Health Care: national results of PMAQ-AB. Saúde Debate. 2018; 42(spe1):52-66. doi: https://doi.org/10.1590/0103-11042018S104

Ribeiro LA, Scatena JH. The evaluation of primary health care in Brazil: an analysis of the scientific production between 2007 and 2017. Saúde Soc. 2019; 28(2):95-110. doi: https://doi.org/10.1590/S0104-12902019180884

Mendes AHL, Torres ACS, Belém MO. Understan- ding of popular health education by a Family Health Strategy team. Ciênc Cuid Saúde. 2021; 20:e5210. doi: https://doi.org/10.4025/cienccuidsaude.v20i0.52101

Cheffer MH, Rissi GP, Shibukawa BMC, Higarashi IH. Prescrição e uso de metilfenidato na atenção infanto-juvenil: uma revisão integrativa. Rev Neurocienc. 2021; 29:1-19. doi: https://doi.org/10.34024/rnc.2021.v29.11314

Giangaspro EC, Garitaonandia OG, Cambronero ER. Prevention in childhood: not all interventions today will mean more health tomorrow. Rev Asoc Esp Neuropsiq. 2019; 39(135):241-59. doi: http://dx.doi.org/10.4321/s0211-57352019000100013

Bardin L. Análise de conteúdo. Lisboa: Edições 70; 2016.

Fermo VC, Alves TF, Boell JEW, Tourinho FSV. Nur- sing consultation in coping with COVID-19: experiences in primary health care. Rev Eletr Enferm. 2021; 23:65893. doi: https://doi.org/10.5216/ree.v23.65893

Tartari RR, Swardfager W, Salum GA, Rohde LA, Moreira HC. Assessing risk of bias in randomized controlled trials of methyphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Int J Methods Psychiatr Res. 2017; 27:e1586. doi: https://doi.org/10.1002/MPR.1586

Santos DAS, Goulart LS, Dourado IJR, Ramon JL, Beltrão BLA. Health education and rational use of medicines at a family health strategy unit. Rev Ciênc Ext [Internet]. 2019 [cited Sep 15, 2021]; 15(1):101-13. Available from: https://ojs.unesp.br/index.php/revista_proex/article/view/1726/2203

Storebo OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database Syst Rev. 2018; 5:CD012069. doi: https://doi.org/10.1002/14651858.CD012069.pub2

Silva JL, Teston EF, Marcon SS, Arruda BCCG, Ramos AR. Perception of health professionals about shared care between primary care and home care. Rev Gaúcha Enferm. 2021; 42:e20200410. doi:https://doi.org/10.1590/1983-1447.2021.20200410

Santos ACS, Volpe CRG, Pinho DLM, Araújo PRS, Silva HTA. Medication errors and incidents in primary care: integrative review. Ciênc Cuid Saúde. 2021; 20:e42645. doi: https://doi.org/10.4025/cienccuidsaude.v20i0.42645

Melo RC, Pauferro MRV. Health education to provide the rational use of medications and the pharmacist’s contributions in this context. Braz J Develop. 2020; 6(5):32162-73. doi: https://doi.org/10.34117/bjdv6n5-603

Cheffer MH, Rodrigues RM, Conterno SFR. Medicalization in the school environment. RELACult. 2018; 4(1):1-14. doi: https://doi.org/10.23899/relacult.v4i1.854

Lopes IE, Nogueira JADR, Dais G. Eixos de ação do Programa Saúde na Escola e Promoção da Saúde: revisão integrativa. Saúde Debate. 2018; 42(118):773-89. doi: https://doi.org/10.1590/0103-1104201811819

Giovanella L, Martufi V, Mendonza DCR, Mendonça MHM, Bousquat A, Aquino R, et al. The contribution of primary health care in the SUS network to face Covid-19. Saúde Debate. 2020; 44(spe 4):161-76. doi: https://dx.doi.org/10.1590/0103-11042020E410

Published
2022-02-04
How to Cite
Cheffer, M. H., Shibukawa, B. M. C., Borges, G. da S., Dietrichkeit, E. T., Campos, T. A., Salci, M. A., & Higarashi, I. H. (2022). Minors using Ritalin: obstacles in Primary Health Care surveillance . Rev Rene, 23, e72148. https://doi.org/10.15253/2175-6783.20222372148
Section
Research Article